Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The main objective of this study is to demonstrate the benefit of the withdrawal of Tacrolimus (Prograf®) on renal function in patients one year after the end of the weaning period. The secondary objectives will focus on assessing the risks and consequences of withdrawal of Tacrolimus (Prograf®).
Critère d'inclusion
- Function of Renal Transplant